Page last updated: 2024-08-16

thalidomide and 3-nitrotyrosine

thalidomide has been researched along with 3-nitrotyrosine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cuzzocrea, S; De Sarro, A; Di Paola, R; Genovese, T; Mazzon, E; Muià, C	1
Aloisi, C; Buemi, M; Crisafulli, C; Cuzzocrea, S; Di Paola, R; Mazzon, E; Mondello, P; Mondello, S	1

Other Studies

2 other study(ies) available for thalidomide and 3-nitrotyrosine

Article	Year
Thalidomide treatment reduces colon injury induced by experimental colitis. Shock (Augusta, Ga.), 2005, Volume: 23, Issue:6 Topics: Animals; Colitis; Colon; Cytokines; Disease Models, Animal; Immunohistochemistry; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Interleukin-1; Mice; Neutrophils; Peroxidase; Poly Adenosine Diphosphate Ribose; Thalidomide; Time Factors; Tumor Necrosis Factor-alpha; Tyrosine; Vascular Endothelial Growth Factor A	2005
Thalidomide suppresses sclerosing encapsulating peritonitis in a rat experimental model. Shock (Augusta, Ga.), 2009, Volume: 32, Issue:3 Topics: Animals; Anti-Infective Agents; Blotting, Western; Chlorhexidine; Disease Models, Animal; Enzyme Activation; Gene Expression Regulation; I-kappa B Proteins; Immunohistochemistry; Immunosuppressive Agents; NF-kappa B; Nitric Oxide Synthase Type II; Peritonitis; Peroxidase; Poly Adenosine Diphosphate Ribose; Rats; Thalidomide; Thiobarbituric Acid Reactive Substances; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Tyrosine; Vascular Endothelial Growth Factor A	2009

Article

Year

Thalidomide treatment reduces colon injury induced by experimental colitis.

Shock (Augusta, Ga.), 2005, Volume: 23, Issue:6

Topics: Animals; Colitis; Colon; Cytokines; Disease Models, Animal; Immunohistochemistry; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Interleukin-1; Mice; Neutrophils; Peroxidase; Poly Adenosine Diphosphate Ribose; Thalidomide; Time Factors; Tumor Necrosis Factor-alpha; Tyrosine; Vascular Endothelial Growth Factor A

2005

Thalidomide suppresses sclerosing encapsulating peritonitis in a rat experimental model.

Shock (Augusta, Ga.), 2009, Volume: 32, Issue:3

Topics: Animals; Anti-Infective Agents; Blotting, Western; Chlorhexidine; Disease Models, Animal; Enzyme Activation; Gene Expression Regulation; I-kappa B Proteins; Immunohistochemistry; Immunosuppressive Agents; NF-kappa B; Nitric Oxide Synthase Type II; Peritonitis; Peroxidase; Poly Adenosine Diphosphate Ribose; Rats; Thalidomide; Thiobarbituric Acid Reactive Substances; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Tyrosine; Vascular Endothelial Growth Factor A

2009